HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,251 | -21.9% | 963 | -25.8% | 0.00% | – |
| Q2 2023 | $110,460 | +6.9% | 1,297 | +4.2% | 0.00% | – |
| Q1 2023 | $103,309 | +11.1% | 1,245 | +5.7% | 0.00% | – |
| Q4 2022 | $93,000 | +12.0% | 1,178 | +4.2% | 0.00% | – |
| Q3 2022 | $83,000 | +6.4% | 1,130 | -5.8% | 0.00% | – |
| Q2 2022 | $78,000 | +34.5% | 1,199 | +12.1% | 0.00% | – |
| Q1 2022 | $58,000 | +18.4% | 1,070 | +14.8% | 0.00% | – |
| Q4 2021 | $49,000 | -54.2% | 932 | -38.2% | 0.00% | – |
| Q3 2021 | $107,000 | +13.8% | 1,508 | +7.0% | 0.00% | – |
| Q2 2021 | $94,000 | -40.5% | 1,410 | -0.6% | 0.00% | – |
| Q1 2021 | $158,000 | -29.8% | 1,418 | -24.7% | 0.00% | -100.0% |
| Q4 2020 | $225,000 | +25.0% | 1,883 | -6.2% | 0.00% | 0.0% |
| Q3 2020 | $180,000 | +1.1% | 2,007 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $178,000 | -3.8% | 1,972 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $185,000 | – | 1,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |